There have been at least three instances where the drug regulator has approved a drug or vaccine but the COVID-19 National Task Force has taken a diametrically opposite stand and not included the drug/vaccine in the national treatment protocol. But the task force was quick to accept the and include the approval given to repurposed … Continue reading Conflicting signals from drug regulator, COVID-19 national task force
Scientists in India are divided over the issue of whether young, healthy children need to be vaccinated in the absence of data showing their risk of suffering from severe disease or death. While there are certain advantages of vaccinating as many people as possible, including young, healthy children, will targeting them result in adults, who … Continue reading Should healthy children be vaccinated on priority?
India's drug regulator has granted an emergency use approval to Zydus Cadila’s antiviral drug ‘Virafin’ to treat moderate COVID-19 disease. In the phase-3 trial, there was a higher proportion of patients administered the drug becoming RT-PCR negative by day seven due to faster viral clearance. The Indian drug regulator on April 23 granted an emergency … Continue reading Zydus Cadila’s antiviral drug for moderate COVID-19 disease gets emergency use approval